Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson’s disease

Cell Transplantation

Volumn 24, Issue 4, 2015, Pages 681-690

  Gonzalez, Rodolfo ^a   Garitaonandia, Ibon ^a   Crain, Andrew ^b   Poustovoitov, Maxim ^a   Abramihina, Tatiana ^a   Noskov, Alexander ^a   Jiang, Chuan ^c   Morey, Robert ^c   Laurent, Louise C ^c   Elsworth, John D ^d,e   Snyder, Evan Y ^b   Eugene Redmond, D ^d,e   Semechkin, Ruslan ^a  

^a INTERNATIONAL STEM CELL CORPORATION   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Axion Research Foundation   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neural stem cells (NSCs); Parkinson s disease (PD); Parthenogenetic stem cells

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; OXIDOPAMINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLOROCEBUS AETHIOPS; CHLOROCEBUS SABAEUS; CLINICAL STUDY; CONTROLLED STUDY; FETUS (ANATOMY); HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NERVOUS TISSUE; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PARTHENOGENETIC STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; SAFETY; ANIMAL; BRAIN; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MPTP POISONING; OOCYTE; PARKINSON DISEASE, SECONDARY; PATHOLOGY; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; TRANSPLANTATION; XENOGRAFT;

ANIMALIA; PRIMATES; RODENTIA;

ANIMALS; BRAIN; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; MPTP POISONING; NEURAL STEM CELLS; OVUM; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84927663119     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368915X687769     Document Type: Article

References (37)

1. Anders, S.; Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11(10):R106; 2010.
2. Becker, M.; Nitsche, A.; Neumann, C.; Aumann, J.; Junghahn, I.; Fichtner, I. Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br. J. Cancer 87(11):1328-1335; 2002.
3. Bjugstad, K. B.; Teng, Y. D.; Redmond, D. E., Jr.; Elsworth, J. D.; Roth, R. H.; Cornelius, S. K.; Snyder, E. Y.; Sladek, J. R., Jr. Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson’s disease. Exp. Neurol. 211(2):362-369; 2008.
4. Borlongan, C. V.; Fournier, C.; Stahl, C. E.; Yu, G.; Xu, L.; Matsukawa, N.; Newman, M.; Yasuhara, T.; Hara, K.; Hess, D. C.; Sanberg, P. R. Gene therapy, cell transplantation and stroke. Front. Biosci. 11:1090-1101; 2006.
5. Brundin, P.; Strecker, R. E.; Gage, F. H.; Lindvall, O.; Bjorklund, A. Intracerebral transplantation of dopamine neurons: Understanding the functional role of the mesolimbocortical dopamine system and developing a therapy for Parkinson’s disease. Ann. N Y. Acad. Sci. 537:148-160; 1988.
6. Cummings, B. J.; Uchida, N.; Tamaki, S. J.; Salazar, D. L.; Hooshmand, M.; Summers, R.; Gage, F. H.; Anderson, A. J. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. USA 102(39):14069-14074; 2005.
7. Elsworth, J. D.; Deutch, A. Y.; Redmond, D. E., Jr.; Taylor, J. R.; Sladek, J. R., Jr.; Roth, R. H. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: Biochemical changes in striatal regions. Neuroscience 33(2):323-331; 1989.
8. Elsworth, J. D.; Sladek, J. R., Jr.; Taylor, J. R.; Collier, T. J.; Redmond, D. E., Jr.; Roth, R. H. Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys. Neuroscience 72(2):477-484; 1996.
9. Elsworth, J. D.; Taylor, J. R.; Sladek, J. R., Jr.; Collier, T. J.; Redmond, D. E., Jr.; Roth, R. H. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience 95(2):399-408; 2000.
10. Emborg, M. E.; Zhang, Z.; Joers, V.; Brunner, K.; Bondarenko, V.; Ohshima, S.; Zhang, S. C. Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant. 22(5):831-838; 2013.
11. Freed, C. R. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson’s disease? Proc. Natl. Acad. Sci. USA 99(4):1755-1757; 2002.
12. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med. 344(10):710-719; 2001.
13. Ganat, Y. M.; Calder, E. L.; Kriks, S.; Nelander, J.; Tu, E. Y.; Jia, F.; Battista, D.; Harrison, N.; Parmar, M.; Tomishima, M. J.; Rutishauser, U.; Studer, L. Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment. J. Clin. Invest. 122(8):2928-2939; 2012.
14. Gonzalez, R.; Garitaonandia, I.; Abramihina, T.; Wambua, G. K.; Ostrowska, A.; Brock, M.; Noskov, A.; Boscolo, F. S.; Craw, J. S.; Laurent, L. C.; Snyder, E. Y.; Semechkin, R. A. Deriving dopaminergic neurons for clinical use. A practical approach. Scientific Reports 3(1463):1-5; 2013.
15. Hallett, P. J.; Cooper, O.; Sadi, D.; Robertson, H.; Mendez, I.; Isacson, O. Long-term health of dopaminergic neuron transplants in Parkinson’s disease patients. Cell.Rep. 7(6): 1755-1761; 2014.
16. Hargus, G.; Cooper, O.; Deleidi, M.; Levy, A.; Lee, K.; Marlow, E.; Yow, A.; Soldner, F.; Hockemeyer, D.; Hallett, P. J.; Osborn, T.; Jaenisch, R.; Isacson, O. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. Acad. Sci. USA 107(36):15921-15926; 2010.
17. Hauser, R. A.; Freeman, T. B.; Snow, B. J.; Nauert, M.; Gauger, L.; Kordower, J. H.; Olanow, C. W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch.Neurol. 56(2):179-187; 1999.
18. Huang, D. W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols 4(1):44-57; 2008.
19. Kefalopoulou, Z.; Politis, M.; Piccini, P.; Mencacci, N.; Bhatia, K.; Jahanshahi, M.; Widner, H.; Rehncrona, S.; Brundin, P.; Bjorklund, A.; Lindvall, O.; Limousin, P.; Quinn, N.; Foltynie, T. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: Two case reports. JAMA Neurol. 71(1):83-87; 2014.
20. Kordower, J. H.; Freeman, T. B.; Snow, B. J.; Vingerhoets, F. J.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Smith, D. A.; Nauert, G. M.; Perl, D. P.; et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. N. Engl. J. Med. 332(17):1118- 1124; 1995.
21. Kriks, S.; Shim, J. W.; Piao, J.; Ganat, Y. M.; Wakeman, D. R.; Xie, Z.; Carrillo-Reid, L.; Auyeung, G.; Antonacci, C.; Buch, A.; Yang, L.; Beal, M. F.; Surmeier, D. J.; Kordower, J. H.; Tabar, V.; Studer, L. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease. Nature 480(7378):547-551; 2011.
22. Mendez, I.; Vinuela, A.; Astradsson, A.; Mukhida, K.; Hallett, P.; Robertson, H.; Tierney, T.; Holness, R.; Dagher, A.; Trojanowski, J. Q.; Isacson, O. Dopamine neurons implanted into people with Parkinson’s disease survive without pathology for 14 years. Nat. Med. 14(5):507-509; 2008.
23. Nikkhah, G.; Bentlage, C.; Cunningham, M. G.; Bjorklund, A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J Neurosci. 14(6):3449- 3461; 1994.
24. Ourednik, J.; Ourednik, V.; Lynch, W. P.; Schachner, M.; Snyder, E. Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 20(11):1103-1110; 2002.
25. Ramsköld, D.; Wang, E. T.; Burge, C. B.; Sandberg, R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput. Biol. 5(12):e1000598; 2009.
26. Redmond, D. E., Jr.; Bjugstad, K. B.; Teng, Y. D.; Ourednik, V.; Ourednik, J.; Wakeman, D. R.; Parsons, X. H.; Gonzalez, R.; Blanchard, B. C.; Kim, S. U.; Gu, Z.; Lipton, S. A.; Markakis, E. A.; Roth, R. H.; Elsworth, J. D.; Sladek, J. R., Jr.; Sidman, R. L.; Snyder, E. Y. Behavioral improvement in a primate Parkinson’s model is associated with multiple homeostatic effects of human neural stem cells. Proc. Natl. Acad. Sci USA 104(29):12175-12180; 2007.
27. Redmond, D. E., Jr.; Vinuela, A.; Kordower, J. H.; Isacson, O. Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson’s disease. Neurobiol. Dis. 29(1):103-116; 2008.
28. Redmond, D. E.; Sladek, J. R., Jr.; Roth, R. H.; Collier, T. J.; Elsworth, J. D.; Deutch, A. Y.; Haber, S. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1(8490):1125-1127; 1986.
29. Revazova, E. S.; Turovets, N. A.; Kochetkova, O. D.; Agapova, L. S.; Sebastian, J. L.; Pryzhkova, M. V.; Smolnikova, V. I.; Kuzmichev, L. N.; Janus, J. D. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 10(1):11-24; 2008.
30. Revazova, E. S.; Turovets, N. A.; Kochetkova, O. D.; Kindarova, L. B.; Kuzmichev, L. N.; Janus, J. D.; Pryzhkova, M. V. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 9(3):432- 449; 2007.
31. Roy, N. S.; Cleren, C.; Singh, S. K.; Yang, L.; Beal, M. F.; Goldman, S. A. Functional engraftment of human ES cellderived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12(11):1259-1268; 2006.
32. Song, P.; Xie, Z.; Guo, L.; Wang, C.; Xie, W.; Wu, Y. Human genome-specific real-time PCR method for sensitive detection and reproducible quantitation of human cells in mice. Stem Cell Rev. 8(4):1155-1162; 2012.
33. Teng, Y. D.; Benn, S. C.; Kalkanis, S. N.; Shefner, J. M.; Onario, R. C.; Cheng, B.; Lachyankar, M. B.; Marconi, M.; Li, J.; Yu, D.; Han, I.; Maragakis, N. J.; Llado, J.; Erkmen, K.; Redmond, D. E., Jr.; Sidman, R. L.; Przedborski, S.; Rothstein, J. D.; Brown, R. H., Jr.; Snyder, E. Y. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci. Transl. Med. 4(165):165ra164; 2012.
34. Uchida, N.; Buck, D. W.; He, D.; Reitsma, M. J.; Masek, M.; Phan, T. V.; Tsukamoto, A. S.; Gage, F. H.; Weissman, I. L. Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci USA 97(26):14720-14725; 2000.
35. Yang, D.; Zhang, Z. J.; Oldenburg, M.; Ayala, M.; Zhang, S. C. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 26(1):55-63; 2008.
36. Yasuhara, T.; Matsukawa, N.; Hara, K.; Yu, G.; Xu, L.; Maki, M.; Kim, S. U.; Borlongan, C. V. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson’s disease. J. Neurosci. 26(48):12497- 12511; 2006.
37. Zhu, Q.; Ma, J.; Yu, L.; Yuan, C. Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats. Neurosci. Lett. 462(3):213-218; 2009.